The global pharmaceutical dissolution testing services market is expected to garner a market value of USD 693.12 Million in 2023 and is expected to accumulate a market value of USD 1,538.48 Million by registering a CAGR of 8.3% in the forecast period 2023 to 2033.
The growth of the pharmaceutical dissolution testing services market can be attributed to a rise in pharmaceutical research efforts. The market for pharmaceutical dissolution testing services registered a CAGR of 5.2% in the historical period 2018 to 2022.
Due to increased Research and Development expenditure by pharmaceutical companies as well as an increase in the number of novel medications entering the preclinical stage of development, there has also been an increase in demand for pharmaceutical dissolution testing services. The dissolution testing services were initially disturbed due to the pandemic.
| Report Attribute | Details |
|---|---|
| Expected Market Value (2023) | USD 693.12 Million |
| Anticipated Forecast Value (2033) | USD 1,538.48 Million |
| Projected Growth Rate (2023 to 2033) | 8.3% CAGR |
According to market research and competitive intelligence provider Future Market Insights- the market for pharmaceutical dissolution testing services reflected a value of 5.2% during the historical period, 2018 to 2022.
The COVID-19 pandemic has significantly impacted the global industry. Pharmaceutical firms, biotech firms, and other end-user demands were primarily served during the crisis by developing coronavirus prevention drugs. Since the end of 2019, these organizations have been actively working toward the development of medications that can be used as a treatment for COVID-19 patients who have only minor symptoms.
And these drug developments require dissolution testing at each stage to access safety, stability, and efficacy, thus contributing to industry growth. Thus, the market for pharmaceutical dissolution testing services is expected to register a CAGR of 8.3% in the forecast period 2023 to 2033.
Research for Prevention of COVID-19 leading to demand for Pharmaceutical Dissolution Testing Services
The pandemic created an increased workload and a reduction in the internal lab testing capacities of various pharmaceutical companies. However, to mitigate or prevent these challenges, various strategies, like rotational shifts, reducing manpower, and working from home were adopted by companies. By the second half of the pandemic, the research studies for drug development started for the prevention of COVID-19 led to a rise in demand for pharmaceutical dissolution testing services. Dissolution testing is an essential tool for assessing the effectiveness of oral solid dose forms.
Its importance is rising due to the fact that medicine must first be released from the product and dissolved in the gastrointestinal fluids before it can be absorbed into the blood vessels to be effective. In other words, how quickly and how much of a medicine is absorbed depends on how easily it dissolves from the dosage form. According to The Food and Drug Administration Dissolution Database, there are 1444 drug products (July 2022) in the database that are in oral solid dose form. The oral solid dose is relatively simple to administer and it is simple to differentiate one oral solid dose product from another.
Marketing Efforts and Awareness regarding Healthcare Products bolstering demand for Pharmaceutical Dissolution Testing Services
Oral solid dose manufacturing approaches are well-developed. Each has a repeatable distribution of ingredients, as well as uniformity in dissolution and bioavailability, to verify that the drug product is safe and effective. The performance of key companies is highly influenced by the level of demand from end users.
Due to intense market efforts, increasing awareness levels, improving accessibility, and government initiatives; consumers, these days, are more concerned about self-care, resulting in higher consumption of healthcare products. The consumption levels are anticipated to rise exponentially over the forecast period.
Unskilled Workforce affecting the growth of the Pharmaceutical Dissolution Testing Services Market
The pharmaceutical dissolution testing services are at a nascent stage. Thus, the trial-and-error format of the industry is hampering the overall growth of the market. Moreover, the absence of unskilled labor to perform various testing services tasks is retaining the growth of the market. Although key players are using technology to increase production and testing services, the unavailability of skilled labor is causing losses to the industry.
Research and Development for Novel Therapeutics accelerating market growth in North America
North America is expected to dominate the global industry in 2023 and account for the maximum share exceeding 50% of the overall revenue. The high share of this segment can be attributed to the presence of major companies providing pharmaceutical dissolution testing services and rising investments in Research and Development by them for the development of novel therapeutics for chronic diseases.
In addition, the development of the healthcare system and a rise in the burden of disease have increased the demand for novel therapeutics and, in turn, the demand for laboratory dissolution testing. All these factors are propelling the growth of the pharmaceutical dissolution testing services market in North America.
Government Initiatives for Research and Development supporting the growth of the market in Asia Pacific
The Asia Pacific region is expected to grow at the fastest CAGR during the forecast period owing to the rising investments by companies from developed economies in enhancing regional healthcare. Furthermore, service providers are establishing new facilities and forming alliances to increase the reach of their offerings to various locations in the region.
In addition, the government of the region is focusing on offering investments for research and development that will accelerate the manufacturing of medicines for different ailments. Thus, Asia Pacific is expected to possess a 33% market share for the pharmaceutical dissolution testing services market in Asia Pacific.
In-vitro dissolution testing is used to evaluate the security of medicines
The in-vitro method segment is expected to dominate the global market in 2023 and account for the largest share of more than 58% of the overall revenue.
The segment is projected to expand further at the fastest growth rate maintaining its leading industry position throughout the forecast period. Two key factors driving the segment growth include an increase in preclinical pipeline capacity and growing awareness about dissolution testing.
In addition, the market for in-vitro pharmaceutical dissolution testing is anticipated to rise as a result of the traditional rising costs of animal tests as well as their socio-ethical problems. Market expansion is predicted to be supported by significant developments in the in-vitro dissolution testing assays used to evaluate the security of medicines and the potential impacts of those drugs on cells and tissues.
To accommodate the rising demand for these assays, businesses are increasing their product lines as the market for in-vitro pharmaceutical dissolution testing expands.
Easy formulation and availability of tablets increasing production of capsules
Based on dosage form, the global industry has been further categorized into capsules, tablets, and others. The other segment includes syrup, ointments, eye/ear/nasal drops, powders, and aerosols.
The tablet dosage form segment is expected to dominate the global industry in 2023 and account for the maximum share of 65% of the overall revenue. The segment is also anticipated to register the fastest CAGR maintaining its leading industry position throughout the forecast period.
This rapid growth can be attributed to the fact that tablets are simple to produce in large quantities, have excellent physical and chemical stability, and can be adjusted for the amount of medicine supplied to the body. The capsules segment is anticipated to register the second-fastest CAGR during the forecast period. Capsules are solid dosage forms. Some of the major drivers of this segment are the stability, easy availability of storage conditions, and easy formulation & development of capsules.
Easy Allowance of pH change maximizing use of paddle for manufacturing tablets
Based on dissolution apparatus, the global industry has been further categorized into basket, paddle, and others. The other segment includes a reciprocating cylinder, flow-through cell, paddle-over disc, rotating cylinder, and reciprocating disc. The paddle segment is expected to dominate the industry and account for the largest revenue share of 70% in 2023.
The paddle is fixed vertically to a motor with variable speed and controlled speed. The tablet or capsule is put into a flask with a circular bottom for dissolving, and the equipment is kept at a steady temperature. This is widely used for the oral solid dosage form.
It is easy to use, can change pH, and can be easily automated for a routine check-up. The basket dissolution apparatus segment is likely to register the second-fastest CAGR during the forecast period. New equipment is positioned at the revolving shaft's end when using the basket dissolution method.
It is made of non-reactive mesh and has a cylindrical form to avoid any unintended chemical interactions that might change the outcome. The main driver for the wide-scale adoption of this method is it can change its pH during the test.
Businesses are undertaking strategies like product launches, M&A agreements, regional expansions, and product launches to gain a competitive edge. Some of the prominent players in the global pharmaceutical dissolution testing services market include Intertek Group Plc, Avivia BV, Almac Group, Agilent Technologies, Inc., Catalent, Inc., Thermofisher Scientific Inc, Cambrex, Charles River Laboratories, Boston Analytical, Pace Analytical Life Sciences, SOTAX, AMRI, SGS SA
| Report Attribute | Details |
|---|---|
| Market Value in 2023 | USD 693.12 Million |
| Market Value in 2033 | USD 1,538.48 Million |
| Growth Rate | CAGR of 8.3% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD Million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Method, Dosage Form, Dissolution Apparatus, Region |
| Regions Covered | North America; Latin America; Europe; Asia Pacific; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, China, Japan, South Korea, Singapore, Thailand, Indonesia, Australia, New Zealand, GCC Countries, South Africa, Israel |
| Key Companies Profiled | Intertek Group Plc.; Aviva BV; Almac Group; Agilent Technologies, Inc.; Catalent, Inc.; Thermo Fisher Scientific Inc.; Cambrex; Charles River Laboratories; Boston Analytical; Pace Analytical Life Sciences; SOTAX; AMRI; SGS SA |
| Customization | Available Upon Request |
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Method, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 4: Global Market Value (US$ Million) Forecast by Dissolution Apparatus, 2018 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by Method, 2018 to 2033
Table 7: North America Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 8: North America Market Value (US$ Million) Forecast by Dissolution Apparatus, 2018 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 10: Latin America Market Value (US$ Million) Forecast by Method, 2018 to 2033
Table 11: Latin America Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 12: Latin America Market Value (US$ Million) Forecast by Dissolution Apparatus, 2018 to 2033
Table 13: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: Europe Market Value (US$ Million) Forecast by Method, 2018 to 2033
Table 15: Europe Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 16: Europe Market Value (US$ Million) Forecast by Dissolution Apparatus, 2018 to 2033
Table 17: Asia Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 18: Asia Pacific Market Value (US$ Million) Forecast by Method, 2018 to 2033
Table 19: Asia Pacific Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 20: Asia Pacific Market Value (US$ Million) Forecast by Dissolution Apparatus, 2018 to 2033
Table 21: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 22: MEA Market Value (US$ Million) Forecast by Method, 2018 to 2033
Table 23: MEA Market Value (US$ Million) Forecast by Dosage Form, 2018 to 2033
Table 24: MEA Market Value (US$ Million) Forecast by Dissolution Apparatus, 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Method, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Dissolution Apparatus, 2023 to 2033
Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 8: Global Market Value (US$ Million) Analysis by Method, 2018 to 2033
Figure 9: Global Market Value Share (%) and BPS Analysis by Method, 2023 to 2033
Figure 10: Global Market Y-o-Y Growth (%) Projections by Method, 2023 to 2033
Figure 11: Global Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 12: Global Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 13: Global Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 14: Global Market Value (US$ Million) Analysis by Dissolution Apparatus, 2018 to 2033
Figure 15: Global Market Value Share (%) and BPS Analysis by Dissolution Apparatus, 2023 to 2033
Figure 16: Global Market Y-o-Y Growth (%) Projections by Dissolution Apparatus, 2023 to 2033
Figure 17: Global Market Attractiveness by Method, 2023 to 2033
Figure 18: Global Market Attractiveness by Dosage Form, 2023 to 2033
Figure 19: Global Market Attractiveness by Dissolution Apparatus, 2023 to 2033
Figure 20: Global Market Attractiveness by Region, 2023 to 2033
Figure 21: North America Market Value (US$ Million) by Method, 2023 to 2033
Figure 22: North America Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 23: North America Market Value (US$ Million) by Dissolution Apparatus, 2023 to 2033
Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 28: North America Market Value (US$ Million) Analysis by Method, 2018 to 2033
Figure 29: North America Market Value Share (%) and BPS Analysis by Method, 2023 to 2033
Figure 30: North America Market Y-o-Y Growth (%) Projections by Method, 2023 to 2033
Figure 31: North America Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 32: North America Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 33: North America Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 34: North America Market Value (US$ Million) Analysis by Dissolution Apparatus, 2018 to 2033
Figure 35: North America Market Value Share (%) and BPS Analysis by Dissolution Apparatus, 2023 to 2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by Dissolution Apparatus, 2023 to 2033
Figure 37: North America Market Attractiveness by Method, 2023 to 2033
Figure 38: North America Market Attractiveness by Dosage Form, 2023 to 2033
Figure 39: North America Market Attractiveness by Dissolution Apparatus, 2023 to 2033
Figure 40: North America Market Attractiveness by Country, 2023 to 2033
Figure 41: Latin America Market Value (US$ Million) by Method, 2023 to 2033
Figure 42: Latin America Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 43: Latin America Market Value (US$ Million) by Dissolution Apparatus, 2023 to 2033
Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 48: Latin America Market Value (US$ Million) Analysis by Method, 2018 to 2033
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Method, 2023 to 2033
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Method, 2023 to 2033
Figure 51: Latin America Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 54: Latin America Market Value (US$ Million) Analysis by Dissolution Apparatus, 2018 to 2033
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Dissolution Apparatus, 2023 to 2033
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Dissolution Apparatus, 2023 to 2033
Figure 57: Latin America Market Attractiveness by Method, 2023 to 2033
Figure 58: Latin America Market Attractiveness by Dosage Form, 2023 to 2033
Figure 59: Latin America Market Attractiveness by Dissolution Apparatus, 2023 to 2033
Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 61: Europe Market Value (US$ Million) by Method, 2023 to 2033
Figure 62: Europe Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 63: Europe Market Value (US$ Million) by Dissolution Apparatus, 2023 to 2033
Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 68: Europe Market Value (US$ Million) Analysis by Method, 2018 to 2033
Figure 69: Europe Market Value Share (%) and BPS Analysis by Method, 2023 to 2033
Figure 70: Europe Market Y-o-Y Growth (%) Projections by Method, 2023 to 2033
Figure 71: Europe Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 72: Europe Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 73: Europe Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 74: Europe Market Value (US$ Million) Analysis by Dissolution Apparatus, 2018 to 2033
Figure 75: Europe Market Value Share (%) and BPS Analysis by Dissolution Apparatus, 2023 to 2033
Figure 76: Europe Market Y-o-Y Growth (%) Projections by Dissolution Apparatus, 2023 to 2033
Figure 77: Europe Market Attractiveness by Method, 2023 to 2033
Figure 78: Europe Market Attractiveness by Dosage Form, 2023 to 2033
Figure 79: Europe Market Attractiveness by Dissolution Apparatus, 2023 to 2033
Figure 80: Europe Market Attractiveness by Country, 2023 to 2033
Figure 81: Asia Pacific Market Value (US$ Million) by Method, 2023 to 2033
Figure 82: Asia Pacific Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 83: Asia Pacific Market Value (US$ Million) by Dissolution Apparatus, 2023 to 2033
Figure 84: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033
Figure 85: Asia Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 88: Asia Pacific Market Value (US$ Million) Analysis by Method, 2018 to 2033
Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Method, 2023 to 2033
Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Method, 2023 to 2033
Figure 91: Asia Pacific Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 94: Asia Pacific Market Value (US$ Million) Analysis by Dissolution Apparatus, 2018 to 2033
Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by Dissolution Apparatus, 2023 to 2033
Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by Dissolution Apparatus, 2023 to 2033
Figure 97: Asia Pacific Market Attractiveness by Method, 2023 to 2033
Figure 98: Asia Pacific Market Attractiveness by Dosage Form, 2023 to 2033
Figure 99: Asia Pacific Market Attractiveness by Dissolution Apparatus, 2023 to 2033
Figure 100: Asia Pacific Market Attractiveness by Country, 2023 to 2033
Figure 101: MEA Market Value (US$ Million) by Method, 2023 to 2033
Figure 102: MEA Market Value (US$ Million) by Dosage Form, 2023 to 2033
Figure 103: MEA Market Value (US$ Million) by Dissolution Apparatus, 2023 to 2033
Figure 104: MEA Market Value (US$ Million) by Country, 2023 to 2033
Figure 105: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 106: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 107: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 108: MEA Market Value (US$ Million) Analysis by Method, 2018 to 2033
Figure 109: MEA Market Value Share (%) and BPS Analysis by Method, 2023 to 2033
Figure 110: MEA Market Y-o-Y Growth (%) Projections by Method, 2023 to 2033
Figure 111: MEA Market Value (US$ Million) Analysis by Dosage Form, 2018 to 2033
Figure 112: MEA Market Value Share (%) and BPS Analysis by Dosage Form, 2023 to 2033
Figure 113: MEA Market Y-o-Y Growth (%) Projections by Dosage Form, 2023 to 2033
Figure 114: MEA Market Value (US$ Million) Analysis by Dissolution Apparatus, 2018 to 2033
Figure 115: MEA Market Value Share (%) and BPS Analysis by Dissolution Apparatus, 2023 to 2033
Figure 116: MEA Market Y-o-Y Growth (%) Projections by Dissolution Apparatus, 2023 to 2033
Figure 117: MEA Market Attractiveness by Method, 2023 to 2033
Figure 118: MEA Market Attractiveness by Dosage Form, 2023 to 2033
Figure 119: MEA Market Attractiveness by Dissolution Apparatus, 2023 to 2033
Figure 120: MEA Market Attractiveness by Country, 2023 to 2033
From 2018 to 2022, the pharmaceutical dissolution testing services market grew at a CAGR of 5.2%
The global pharmaceutical dissolution testing services market is expected to grow with an 8.3% CAGR from 2023 to 2033.
As of 2033, the pharmaceutical dissolution testing services market is expected to reach USD 1538.48 Million
The tablet dosage form segment is expected to dominate the global industry in 2023 and account for the maximum share of more than 65% of the overall revenue.
The paddle segment is expected to dominate the industry and account for the largest revenue share of more than 70% in 2023.
The in-vitro method segment is expected to dominate the global market in 2023 and account for the largest share of more than 58% of the overall revenue.
North America is expected to dominate the global industry in 2023 and account for the maximum share of more than 50% of the overall revenue.
Asia Pacific is expected to possess a 33% market share for the pharmaceutical dissolution testing services market in Asia Pacific.
Explore Healthcare Services Insights
Pharmaceutical Dissolution Testing Services Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
